Publicacións en colaboración con investigadores/as de University of Nottingham (3)

2024

  1. Insulin-like peptide 3 (INSL3) as an indicator of leydig cell insufficiency (LCI) in Middle-aged and older men with hypogonadism: reference range and threshold

    Aging Male, Vol. 27, Núm. 1

2022

  1. Association of age, hormonal, and lifestyle factors with the Leydig cell biomarker INSL3 in aging men from the European Male Aging Study cohort

    Andrology, Vol. 10, Núm. 7, pp. 1328-1338

  2. The Leydig cell biomarker INSL3 as a predictor of age-related morbidity: Findings from the EMAS cohort

    Frontiers in Endocrinology, Vol. 13